Author contribution
All authors have made substantial contribution to the case report.SY (Consultant obstetrician) and MH (Pharmacy
Executive Director) has contributed to the conceptualization of the case
report and were responsible for supervision, planning and execution.SH is a senior consultant and head of obstetric emergency who
was involved in the initial assessment of the case. ZM is the
primary obstetrician (senior consultant) who was involved in treating
the case along with TR & IB (obstetric consultant) andMJ (specialist obstetrician). AA is a senior research
fellow and ECMO consultant who managed the case in intensive care unit.AM is a senior consultant at the emergency department, involved
in the initial management of the case. MM is infectious disease
consultant and provided valuable input to the manuscript and managing
the COVID-19 and related complications. AT and FM have
contributed by interpreting the laboratory and radiological findings.HS is consultant neonatologist who managed the newborn in the
NICU. PR and WK are pharmacy administrative, involved
in the acquisition of the financial support, scientific review and
verification for the validity of content. BT is a clinical
pharmacy specialist and doctoral researcher who took the lead in writing
the manuscript in consultation with SY, MH, AM, PR, FM . All
authors discussed, reviewed and edited the case report. All authors
agreed to the final version prior to its submission.